KBIO LABS (038530) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, KBIO LABS (038530) reported revenue of 87.3 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202587.3 billion KRW1.5 billion KRW-5.0 billion KRW[source]
202476.5 billion KRW793 million KRW-10.0 billion KRW[source]
202327.3 billion KRW-561 million KRW-12.7 billion KRW[source]
202233.6 billion KRW-153 million KRW-7.7 billion KRW[source]
20218.7 billion KRW-4.8 billion KRW-19.5 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202562.6 billion KRW9.4 billion KRW53.2 billion KRW[source]
202461.2 billion KRW4.9 billion KRW56.3 billion KRW[source]
202368.6 billion KRW5.4 billion KRW63.2 billion KRW[source]
202282.4 billion KRW15.6 billion KRW66.8 billion KRW[source]
202187.4 billion KRW24.4 billion KRW63.0 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice